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Abstract
Rationale Psychosis susceptibility is mediated in part by
the dopaminergic neurotransmitter system. In humans,
individual differences in vulnerability for psychosis are
reflected in differential sensitivity for psychostimulants
such as amphetamine. We hypothesize that the same genes
and pathways underlying behavioral sensitization in mice
are also involved in the vulnerability to psychosis.
Objectives The aim of the current study was to investigate
which genes and pathways may contribute to behavioral
sensitization in different dopaminergic output areas in the
mouse brain.
Methods We took advantage of the naturally occurring
difference in psychostimulant sensitivity in DBA/2 mice
and selected animals displaying extremes in behavioral
sensitization to amphetamine. Subsequently, the dopamine
output areas, prefrontal cortex, nucleus accumbens, and cornu
ammonis 1 (CA1) area of the hippocampus, were isolated by
laser microdissection and subjected to DNA microarray
analysis 1 h after a challenge dose of amphetamine.
Results A large number of genes with differential expres-
sion between high and low responders were identified, with
no overlap between brain regions. Validation of these gene
expression changes with real-time quantitative polymerase
chain reaction demonstrated that the most robust and
reproducible effects on gene expression were in the CA1
region of the hippocampus. Interestingly, many of the
validated genes in CA1 are members of the cAMP response
element (CRE) family and targets of the glucocorticoid
receptor (GR) and myocyte enhancer factor 2 (Mef2)
transcription factors.
Conclusion We hypothesize that CRE, Mef2, and GR
signaling form a transcription regulating network, which
underlies differential amphetamine sensitivity, and therefore,
may play an important role in susceptibility to psychosis.
Keywords Mouse.Brain.Psychosis.Amphetamine
sensitization.Laser microdissection.Gene expression.
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Psychosis is characterized by a gradual loss of contact with
reality, progressing from emotional instability, acoustic and
visual disturbances, and decreased discriminative ability for
real and surreal ideas and memories to more pronounced
symptoms like hallucinations, delusions, and thought
disorders. Psychotic-like symptoms can be induced by
psychostimulant drugs like amphetamine (Janowsky and
Risch 1979). Patients with a high susceptibility for
psychosis, such as schizophrenia patients, display an
increased sensitivity to amphetamine (Strakowski et al.
1997) that resembles the behavioral sensitization found in
rodents after repeated exposure to amphetamine (Alessi et
al. 2003; Peleg-Raibstein et al. 2006, 2008; Tenn et al.
2003). This behavioral sensitization is characterized by a
progressive and persisting increase in the behavioral
activity and neurochemical responses to psychostimulants,
such as stimulation of locomotor activity, stereotypy, and
dopamine (DA) release in the striatum (Featherstone et al.
2007; Laruelle and Abi-Dargham 1999; Morrens et al.
2006). Moreover, the number of DA D2 receptors in the
high-affinity conformational state is altered in the striatum,
whereas the total expression of DA D2 receptors is not
changed in both sensitized animals and schizophrenia patients
(Seeman et al. 2005, 2007). Substantial interindividual
differences exist in susceptibility to develop psychosis as
well as in sensitivity to amphetamine (Alessi et al. 2003). It
has been hypothesized that individuals that are more
sensitive to amphetamine are also more susceptible to
become psychotic (Post 1992; Segal et al. 1981). Based on
these similarities, the amphetamine sensitization model can
be considered a promising animal model to study several
aspects of schizophrenia (Featherstone et al. 2007).
Persistent neuroplastic alterations in the reward circuitry,
in particular in the mesolimbic DA pathway, are associated
with the expression of behavioral sensitization (Nestler
2005a). The mesolimbic DA pathway originates in the
ventral tegmental area (VTA) and projects to the nucleus
accumbens (NAc), amygdala, prefrontal cortex (PFC), and
other forebrain regions including the cornu ammonis 1
(CA1) subregion of the hippocampus (Floresco et al. 2001;
Gasbarri et al. 1994; Thierry et al. 2000). Induction and
expression of behavioral sensitization to psychostimulants
is a complex process in which various neurotransmitters, in
particular DA and glutamate, result in downstream molec-
ular adaptations in the VTA–NAc circuitry and other limbic
brain regions. In the VTA, enhanced glutamatergic
neurotransmission results in a sensitized state resembling
long-term potentiation. In the NAc, induction of the
transcription factors ΔFosB and cAMP response element
binding (CREB) appear to be common adaptations in
response to chronic exposure to drugs of abuse, contrib-
uting to the sensitized state (McClung and Nestler 2003;
McClung et al. 2004; Nestler 2005b; Shaw-Lutchman et
al. 2003). In addition, the extracellular signal-regulated
kinase (ERK) pathway and cAMP-independent activation of
protein kinase B (Akt)-GSK-3 (glycogen synthase kinase 3)
signaling may also play a role in long-lasting behavioral
sensitization (Beaulieu et al. 2007; Emamian et al. 2004;
Valjent et al. 2006). However, still a lot remains unresolved
regarding the molecular events that contribute to behavioral
sensitization in different brain regions of the mesolimbic DA
circuitry.
Theaimofthecurrentstudywastoinvestigatewhichgenes
and pathways may contribute to behavioral sensitization in
different parts of the mesolimbic circuitry in the mouse brain.
We hypothesize that the same genes and pathways underlying
behavioral sensitization are also involved in the vulnerability
to psychosis. To investigate these molecular pathways, we
took advantage of the naturally occurring variability in
behavioral sensitization to amphetamine in DBA/2 mice, an
inbred mouse line (de Jong et al. 2007), thus ruling out the
influence of genetic differences. We developed a sensitiza-
tion regimen that allowed us to separate mice in two distinct
groups showing very high sensitization and no sensitization
to amphetamine, respectively, despite the exact same
amphetamine treatment. Large-scale gene expression profiles
were generated of several dopaminergic output brain regions,
including the CA1 region of the hippocampus, the NAc, and
PFC in mice selected for extremes in behavioral sensitization
to amphetamine, in search of susceptibility genes and
pathways underlying the differential behavioral sensitization.
Materials and methods
Drugs D-Amphetamine ((+)-α-methylphenethylamine sul-
fate; Unikem A/S, Copenhagen, Denmark) was dissolved in
0.9% sodium chloride. Doses are listed as salt equivalents
(in milligrams per kilogram).
Animals Animal experiments were in accordance with the
guidelines issued by the Danish Animal Experimentation
Inspectorate. DBA/2 mice (Charles River Laboratories,
Salzfeld, Germany) were housed four mice per cage in a
temperature- and humidity-controlled environment at a 12-
h light–dark cycle. During the experiment, animals had ad
libitum access to water and food. Mice were left undis-
turbed for 14 days prior to initiation of the experiments.
Amphetamine sensitization In experiment 1, mice were
divided into four groups based on the treatment received during
days 1–5 and on day 20, respectively: group 1 (amph/amph,
n=100), group 2 (sal/sal, n=10), group 3 (sal/amph, n=10),
and group 4 (amph/sal, n=10). Animals received either
526 Psychopharmacology (2011) 217:525–538D-amphetamine(2.5mg/kg)or saline for five consecutive days
(days 1–5). After a 14-day withdrawal period, animals were
given a low-dose amphetamine challenge (1.25 mg/kg) or
saline (day 20) (for a detailed scheme, see Fig. 1). At the drug
challenge (day 20), locomotor behavior was assessed as
described below. Based on the locomotor response to the
amphetamine challenge on day 20, the 10% amph/amph
animals with the highest locomotor response were designated
high responders (HR; n=10), while the 10% animals with the
lowest response were designated low responders (LR; n=10).
The HR and LR were used for subsequent gene expression
analysis.
In a follow-up experiment (experiment 2), it was
investigated whether the HR and LR phenotype is stable.
An e wb a t c ho fa n i m a l sw a ss u b j e c t e dt ot h es a m e
treatment and dosing regimen as in the first study. The
selected 10% HR and LR of the amph/amph group (n=10
each) on day 20 were subsequently left undisturbed for an
additional 7 days and rechallenged with 1.25 mg/kg on
day 27 and locomotor behavior was measured again
(Fig. 1). The HR and LR were used for revalidation of
gene expression changes measured in experiment 1.
Locomotor behavior Animals were placed individually in
Makrolon locomotor activity cages (20×35×18 cm;
Lundbeck). Following a 60-min habituation period,
amphetamine or vehicle was administered and locomotor
activity was recorded for an additional 60 min. The
locomotor activity cages were equipped with 5×8 infrared
light sources plus photocells. The light beams crossed the
cage 1.8 cm above the bottom of the cage. During the
test session, locomotor activity was recorded as crossings
of infrared light beams, and total locomotor count
represents the accumulated number of crossings over
the 60-min period. The recording of a motility count
required interruption of two adjacent light beams, thus
avoiding counts induced by stationary movements of the
mice. All experiments were conducted during the light
phase of the cycle and initiated using a clean cage.
Tissue dissection Selected mice were sacrificed directly
after the locomotor activity measurement on day 20
(experiment 1) and on day 27 (follow-up experiment 2).
Brains were rapidly dissected and snap frozen in isopentane
(cooled in ethanol placed on pulverized dry ice) and stored
at −80°C for later use.
Brain amphetamine levels Amphetamine in total brain
homogenates was measured in two groups (n=10 each) of
mice with locomotor activity counts just below the highest
and just above the lowest responders. Amphetamine levels
were measured by liquid chromatography/tandem mass
spectrometry (LC–MS/MS) to test whether differences in
responsiveness could be accounted for by differences in
brain drug exposure. Brain tissue was homogenated with
four times its weight of acetonitrile/water (70:30) using a
Tomtec Autogizer. The supernatant was analyzed like plasma.
Online sample preparation and LC were performed with
turbulent flow chromatography (Cohesive Technologies,
UK), using a dual-column configuration. MS/MS detection
was done with an Applied Biosystems Sciex API 3000
instrument in positive ion electrospray ionization mode.
Laser microdissection Laser microdissection (LMD) was
performed as previously described (Datson et al. 2004)o n
brain tissue from experiment 1. Briefly, coronal brain
sections (8 μm) were cut using a cryostat at −18°C.
According to the Mouse Brain Atlas (Franklin and Paxinos
Fig. 1 a Animals received either D-amphetamine (2.5 mg/kg) or
saline for five consecutive days (days 1–5). After a 14-day withdrawal
period (day 20), animals were given a low-dose amphetamine
challenge (1.25 mg/kg) or saline and the 10% population extremes
in the amph/amph group (LR and HR) were selected. In the expression
profiling study, mice were sacrificed 1 h after the challenge on day 20
(experiment 1). b In the follow-up study (experiment 2), the LR and
HR received an additional amphetamine (1.25 mg/kg) challenge on
day 27 and were sacrificed 1 h later. Locomotor tests were performed
on the indicated days
Psychopharmacology (2011) 217:525–538 5271997), cryosections from CA1 area were collected starting
at bregma −1.58, NAc cryosections between bregma +1.70
and +1.18, and PFC cryosections (prelimbic and infralimbic
cortex) between bregma +2.80 and +2.10. Both hemi-
spheres were used for sectioning. Cryosections were thaw
mounted on PEN membrane slides (1440-1000, PALM,
Bernried, Germany) which had been pretreated by heating
for 4 h at 180°C and subsequent UV irradiation for 30 min
at 254 nm. After sectioning, the slices were kept at −80°C
until further use. On the day of LMD, the slides were
briefly stained with hematoxylin (10%), dehydrated in
70%, 95%, and 100% ethanol, briefly dipped in xylene,
and dried at 40°C. Immediately afterwards, the slides were
used for LMD on a PALM MicroLaser System (PALM,
Bernried, Germany) and the laser microdissected tissue
fragments were collected in adhesive caps (1440-0250
PALM, Bernried, Germany). A conservative estimate of
CA1 was taken to avoid contamination with CA2/CA3. For
NAc, an area containing both the core and shell was dissected.
For PFC, both prelimbic and medial orbital cortical regions
were combined (Fig. 2). Per mouse, a total of four sections
were dissected and pooled to constitute a sample for
subsequent linear amplification and microarray hybridization.
RNA isolation, linear amplification, and microarray
hybridization Immediately after LMD, RNA was isolated
using Trizol (15596-026, Invitrogen Life Technologies,
Carlsbad, CA, USA) using the manufacturer’s protocol.
Linear acrylamide was added as a carrier. RNA quality and
quantity were checked by analyzing 1 μl of RNA on the
Agilent 2100 Bioanalyzer using the RNA 6000 Pico
LabChip Kit (5065-4473, Agilent Technologies, Palo Alto,
USA). Ten nanograms of total RNA was used for the first
round of linear amplification using the GeneChip One-
Cycle Target Labeling and Control Reagents (P/N 900493,
Affymetrix, Santa Clara, CA, USA). For the second round
of amplification, 100 ng of input RNA was used, during
which the RNA was biotin-labeled using the GeneChip
Two-Cycle Target Labeling and Control Reagents (P/N
900494, Affymetrix, Santa Clara, CA, USA).
GeneChip hybridization Twenty micrograms of biotinylated
RNAwassubsequentlyfragmentedusingRNAFragmentation
Reagents (No. AM8740, Ambion, Austin, TX, USA). The
biotinylated and fragmented RNA was hybridized to Gene-
Chip Mouse Genome 430 2.0 arrays (Affymetrix), containing
approximately 45,000 probe sets representing 39,000 tran-
scripts and 35,000 different genes. Hybridizations were
conducted at the Leiden Genome Technology Center (LGTC,
Leiden University, Leiden, The Netherlands) according to the
manufacturer’s recommendations (Affymetrix, Santa Clara,
USA). A total of 60 microarrays were hybridized, per brain
region 10 HR and 10 LR.
Data analysis Raw images were analyzed and features
extracted using Affymetrix GeneChip Operating Software
(Affymetrix, Foster City, CA, USA). For each brain region,
the resulting CEL files containing probe-level information
were then normalized and converted to gene intensity
values by the GeneChip Robust Multi-array Average (GC-
RMA) algorithm within BRB Arraytools version 3.7.3
developed by Dr. Richard Simon and the BRB Array
Development Team (Simon et al. 2007). To identify
differentially expressed genes, we applied a two-sample
PFC 
CA1 
NAc 
Fig. 2 Scheme showing the
connection between the selected
brain areas including examples
of LMD (indicated by thick
arrows). PFC prefrontal cortex,
IL infralimbic, PL prelimbic,
NAc nucleus accumbens, CA1
cornu ammonis 1 region of the
hippocampus, VTA ventral
tegmental area, Glu glutamate,
DA dopamine, GABA
gamma-aminobutyric acid. Red
arrows indicate glutamatergic
neurons, black arrows indicate
dopaminergic neurons, and blue
arrows indicate GABAergic
neurons (Adapted from Thierry
et. al., 2000)
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comparisonbetweenHRandLR.IngenuityPathwayAnalysis
(IPA; Ingenuity® Systems, http://www.ingenuity.com)v e r -
sion 7.5 was used to identify pathways, networks, and for
gene list matching to published datasets of genes involved in
specific transcription regulation systems (Mef2, cAMP
response element [CRE], and GR). The gene lists for the
specific transcription regulation systems were retrieved from
the supplementary material in the relevant publications
(Pfenning et al. 2007;W ua n dX i e2006; Zhang et al.
2005) and loaded into Ingenuity as comparison datasets.
Real-time quantitative PCR Primers for real-time quantita-
tive polymerase chain reaction (RT-qPCR) validation were
designed using Primer3 freeware within the target sequence
used by Affymetrix for probe design. Primers were checked
for specificity using BLAST (NCBI, Bethesda, MD, USA)
and for hairpins and self-complementarity using oligo 4.0
(MBI, Cascade, CO, USA). The primer sequences of the
validated genes that were measured can be found in
Supplementary Table SI. RT-qPCR measurements were
performed on amplified RNA from experiment 1 to replicate
the results from the GeneChip analysis. cDNA synthesis was
performed using the iScriptTM cDNA Synthesis Kit (170-
8897, Bio-Rad, Hercules, CA, USA) following the manu-
facturer’s protocol. RT-qPCR was performed on a Light-
cycler 2.0 Real-Time PCR System (Roche Applied Science,
Basel, Switzerland) using the Lightcycler FastStart DNA
MasterPLUS SYBR Green I Kit (Roche). The standard
curve method was used to quantify the expression differ-
ences (Livak and Schmittgen 2001). The nonparametric
Mann–Whitney test was used to assess significant differen-
tial gene expression between LR and HR.
Brain tissue from follow-up experiment 2 was used to
replicate the changes in gene expression between LR and
HR found in the CA1 area in an independent experiment.
For this purpose, the dorsal hippocampus was dissected
from frozen brain and eight punches containing CA1 tissue
were obtained from two 1-mm tissue sections. RNA was
synthesized to cDNA without further amplification and RT-
qPCR and data analysis were performed as previously
reported (Christensen et al. 2010) on a selection of genes
that were successfully validated in experiment 1.
Results
DBA/2 mice display large and stable individual differences
in sensitization to amphetamine
The locomotor responses to the challenge dose of amphet-
amine (1.25 mg/kg) or saline on day 20 are depicted in
Fig. 3a. On average, animals that received amphetamine
pretreatment on days 1–5 (amph/amph) were more respon-
sive to the acute amphetamine challenge than saline
pretreated mice (sal/amph), signifying the occurrence of
sensitization. However, a large interindividual variability
was observed in the amph/amph group. The 10% amph/
amph animals with highest locomotor response to amphet-
amine on day 20 were designated HR (n=10), while the
10% animals with the lowest response were designated LR
(n=10). In an independent follow-up study, it was demon-
strated that the HR and LR phenotypes are stable until at
least 1 week after the first drug challenge (Fig. 3b). The
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Fig. 3 a Locomotor responses to the amphetamine (1.25 mg/kg) or
saline challenge on day 20. Data are represented as total activity count
over the 60-min treatment period. sal/sal n=10, sal/amph n=10,
amph/sal n=10, amph/amph n=100. Circles indicate the 10%
population extremes (LR, n=10; HR, n=10) in the amph/amph group
selected for gene expression profiling. b Locomotor responses of the
10% population extremes in the amph/amph group (selected on
day 20) to the amphetamine (1.25 mg/kg) challenges on days 20 and
27. Data are represented as total activity count over the 60-min
treatment period. LR, n=10; HR, n=10. ***p<0.001 vs LR (Mann–
Whitney rank sum test)
Psychopharmacology (2011) 217:525–538 529slight increase in both groups might signify further
incubation of sensitization which is known to occur with
prolonged withdrawal periods.
Amphetamine exposure is not different in HR and LR
Amphetamine in total brain homogenates was measured in
two groups (n=10 each) of mice with locomotor activity
counts just below the highest (21,289±377 counts) and just
above the lowest responders (4,387±406 counts). There
was no correlation between exposure and locomotor
activity (Supplementary data, Figure SI), indicating that
the phenotypic difference in locomotor sensitization could
not be attributed to differences in CNS amphetamine
exposure.
Identification of differentially expressed genes reveals
region-specific molecular signatures
To identify potential molecular changes induced by the
behavioral sensitization, microarray analysis was performed
on PFC, NAc, and hippocampal CA1 regions collected
from 10 HR and 10 LR animals 1 h after a challenge dose
of amphetamine on day 20 (Fig. 1). This time point was
selected in order to examine the early factors behind the
long-term changes induced by the challenge stimulus and,
more importantly, to look under challenged conditions in
which the differences between HR and LR are most
evident. Differentially regulated genes were identified by
statistically comparing GC-RMA mean normalized values
of HR to LR. Of the 45,000 probe sets on the Affymetrix
GeneChip mouse genome 430 2.0 arrays, we identified 63
(39 up, 24 down), 29 (20 up, 9 down), and 105 (76 up, 29
down) genes that significantly differed in expression
between HR and LR in CA1, NAc, and PFC, respec-
tively by two-sample t test (p<0.01, fold change>1.2;
Fig. 4a). These gene lists are referred to as the primary
lists (Supplementary material, Table SII). Comparison of
the three primary lists revealed no overlapping genes
(Fig. 4b). Moreover, pairwise correlation analysis of all
expression values in the 60 samples showed a clear
distinction in region-specific expression signatures
(Fig. 4c). These specific molecular signatures of the
analyzed brain regions most likely reflect both their
specific connectivity and function in a complex circuit as
well as their distinct molecular response to amphetamine
challenge.
Differential expression between HR and LR was most
robust in the hippocampal CA1 region
A total of 83 genes were selected for reconfirmation by RT-
qPCR from all three brain regions based on overall lowest p
value and highest fold change. In both NAc and PFC, the
reconfirmation rates were rather low, with a reconfirmation
rate of 3 out of 24 genes (12.5%) in the NAc and 5 out of
30 genes (16.7%) in the PFC. In the CA1, the reconfirma-
tion rate was considerably higher, with a success rate of 14
out of 28 genes (50.0%).
Gene expression changes in CA1 could be replicated in a
novel independent study.
The expression of several genes that were confirmed to
show differential expression in the CA1 area with RT-qPCR
in the first experiment was validated in an independent
sensitization experiment. Gene expression of six selected
genes (Arc, Nr4a1, Dusp1, Fos, Egr2, and Tiparp) was
quantified in the CA1 of the phenotypically stable animals
that received a second amphetamine challenge (Fig. 1). In
contrast to the validation described above, the six genes
were measured in non-amplified mRNA derived from
manually dissected CA1 rather than LMD. Despite these
technical differences, the results replicated the differential
expression between LR and HR that was shown in the first
study, although Nr4a1 did not reach statistical significance
(Fig. 5).
Validated genes overlap with several gene classes, including
GR-, Mef2-, and CRE-regulated genes
The genes differentially expressed in CA1 were subjected
to IPA. Genes regulated by specific transcription factors or
promoter systems as identified by ChIP/ChIP technology
were identified from the literature and used to compose
gene lists for target genes of transcription factors Mef2,
CREB, GR, and repressor element 1 silencing transcription
factor (REST) (see Supplementary material, Table SIII for
details). Each of the gene lists were compared to the 63
genes identified in CA1 and to a list of 2,000 randomly
selected genes from the entire list of probe sets (∼45,000
probe sets). This comparison indicated a clear overrepre-
sentation of GR, CRE, and Mef2 promoter-regulated genes
among the differentially regulated gene set in CA1 (Fig. 6).
The comparison was repeated with a large number of
randomizations of the R2K set and the differences shown in
Fig. 6 were found to be stable.
Discussion
The aim of this study was to elucidate which genes and
pathways underlie the differences in behavioral response to
amphetamine in genetically identical mice selected for
responsiveness to amphetamine sensitization. The amphet-
amine sensitization model is suggested to reflect the
530 Psychopharmacology (2011) 217:525–538heightened sensitivity of schizophrenia patients to psychos-
timulants and is accepted as a model for the positive
symptoms observed in schizophrenia (Featherstone et al.
2007; Hermens et al. 2009; Peleg-Raibstein et al. 2008,
2009; Tenn et al. 2003). Additionally, there is increasing
evidence for long-lasting cognitive deficits in sensitized
animals (Featherstone et al. 2007). In this study, we used a
unique setup based on genetically identical inbred mice, all
receiving the same treatment yet still displaying differences
in amphetamine sensitization. This is an important
divergence to most studies reporting on gene expression
focusing on differences in outbred strains and/or differ-
ences in treatment (e.g., control vs. amphetamine or
acute vs. chronic amphetamine) (Funada et al. 2004;
Palmer et al. 2005; Shilling et al. 2006; Sokolov et al.
2003). By taking this approach, we are ruling out changes
in gene regulation due to variation in genetic makeup and
different treatment paradigms. Thus, the differential gene
regulation found in the present study most likely reflects
the underlying mechanism for sensitization and may point
to why some individuals get schizophrenia whereas others
do not.
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Fig. 4 a Volcano plots of −log10 (p value) vs. log2 (fold change).
The blue points in each graph indicate the Affymetrix probe sets that
passed the t test p<0.01 and fold change>1.2 statistical requirements.
b Venn diagram of genes differentially expressed between HR and LR.
Genes meeting the fold change>1.2, p<0.01 criteria were included.
No common genes were identified when comparing CA1, PFC, and
NAc. c Correlation matrix of expression levels between all 60 samples
in the experiment. Differential expression between tissues was clearly
identified. Correlation analysis was not able to differentiate between
HR and LR groups
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was found in the CA1 area of the hippocampus. We
observed a considerable variation in sensitization to
amphetamine in DBA/2 mice measured by locomotor
output. Gene expression in CA1, NAc, and PFC, all
dopaminergic output brain areas, of the 10 lowest and 10
highest responders (LR and HR) was assessed 1 h after
amphetamine challenge. Gene expression signatures were
highly brain region-specific, which is not surprising given
that these brain regions differ so extensively in basal
molecular makeup. We found the strongest differential
expression between LR and HR in the CA1 subregion of
the hippocampus. These findings are of interest since most
research on amphetamine-induced gene expression so far
has focused on PFC, striatum, NAc, and VTA (Mirnics et
al. 2000; Palmer et al. 2005; Yuferov et al. 2005) and not
considered CA1 to play a key role in psychostimulant
effects. However, our data are consistent with recent
literature pointing to a prominent role of the hippocam-
pus and DA in schizophrenia (Grace 2010;L i s m a na n d
Grace 2005; Lodge and Grace 2007, 2008; Rossato et al.
2009; for review, see Shohamy and Adcock 2010). In
schizophrenic patients and high-risk individuals, there is
elevated regional cerebral blood volume (rCVB) in the CA1
subregion of the hippocampus, which correlates with positive
symptoms and predicts clinical progression (Gaisler-Salomon
et al. 2009b; Schobel et al. 2009). The increased hippocam-
pal activity linked to psychotic symptoms is in line with data
by Grace et al. (2007) showing how the hippocampus
controls DA neuron activity, possibly by increasing the
number of DA neurons that can be activated by salient
signals. In contrast, antipsychotic phenotype measured as
reduced amphetamine-induced locomotion and release of
DA in the NAc is seen in an animal model with reduced
glutaminase activity, leading to a CA1/subiculum-specific
decrease in rCVB (Gaisler-Salomon et al. 2009a).
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Fig. 5 RT-qPCR validation
results of gene expression
differences between LR
and HR in the CA1 region
of the hippocampus in
the second animal
experiment. **p<0.01 vs LR;
***p<0.001 vs LR
(Mann–Whitney rank sum test)
532 Psychopharmacology (2011) 217:525–538Furthermore, preventing synaptic transmission in the
dorsal region of the hippocampus by local infusion of the
anesthetic lidocaine is able to block the expression of
behavioral sensitization to amphetamine (Degoulet et al.
2008). Finally, Crombag et al. showed that amphetamine
self-administration leads to increased spine density in the
CA1 region of the hippocampus (Goeman et al. 2004).
Although not investigated in the current study, changes in
spine morphology may likely be present in our sensitized
mice. The differences in expression of Mef2 target genes
we identified fit well with a potential difference in spine
density, given that Mef2 is a key regulator of neuronal
plasticity and that manipulating Mef2 expression and
activity directly influences psychostimulant sensitization
(Pulipparacharuvil et al. 2008).
Since we only looked at NAc, PFC, and CA1 in the
current study, we cannot exclude that gene expression
differences in other dopaminergic brain regions may have
contributed to the development of behavioral sensitization,
e.g. the VTA or the amygdala (Yuferov et al. 2005).
However, that would need to be addressed in a follow-up
study.
Immediate early genes Many of the validated genes are
immediate early genes (IEGs), which are among the first
genes to be expressed (hence the name) in a changing
environment. Examples of IEGs identified in this study are
c-fos, Dusp1, Nr4a1, Egr2, Arc, and Tiparp. Several other
studies have also found IEGs to be responsive to amphet-
amine in the brain. Most studies show an upregulation of
IEGs in the striatum in response to acute amphetamine,
while chronic administration has been shown to blunt the
effects of a single dose (for review, see McCoy et al. 2011).
In contrast, Shilling et al. (2006) showed a downregulation
of several IEGs in the PFC of HR 24 h after a single
injection of methamphetamine. Downregulation of IEGs at
such a late time point may represent an adaptive response to
counterbalance the earlier increase in IEG expression as
observed in the present study. One of the IEGs we found to
be upregulated in the HR is c-fos. Interestingly, Zhang et al.
(2006) found that c-fos downregulation in DA D1 receptor-
containing neurons attenuates cocaine-induced behavioral
sensitization. This might indicate that higher c-fos expression
in the HR is a cause rather than a consequence of the
observed increased locomotor response to amphetamine. In
line with our findings for c-fos, two independent studies
show that methamphetamine increases expression of IEG
Arc from 1 h onwards in multiple brain regions, which can
be blocked by giving a DA D1 receptor antagonist (Kodama
et al. 1998; Yamagata et al. 2000). Since many IEGs are
regulated by multiple transcription factors, the question rises
what the link is to the underlying mechanisms of amphet-
amine sensitivity.
GR, Mef2, and Creb are important regulators of sensitiza-
tion. We found a clear overrepresentation of GR, Mef2, and
CRE promoter-regulated genes among the differentially
regulated geneset inCA1 (Fig.6). These transcription factors
are interesting candidates linking the regulation of IEGs to
mechanisms of behavioral sensitization and psychosis
susceptibility.
Glucocorticoids GR, an important receptor for glucocorti-
coid stress hormones in the brain, is a transcription factor
that is able to regulate many of the IEGs as well as some of
the other validated genes that were differentially expressed
between HR and LR in CA1. Stress and more particular
glucocorticoids are factors influencing sensitization to
psychostimulants (Antelman et al. 1980). We have previ-
ously shown that cocaine sensitization in DBA/2 mice
relies in part on corticosterone (de Jong et al. 2007).
Moreover, it was shown that antagonizing GR attenuates
the expression of amphetamine-induced sensitization (De
Vries et al. 1996). Also, in humans, many studies have
shown that psychostimulant abuse and stressful life events
are associated with later-life psychotic episodes, with odds
ratios even increasing with cumulative traumas (Johns et al.
2004; Shevlin et al. 2008; Wiles et al. 2006).
In rodents, a similar link between stress, glucocorticoids,
and behavioral sensitization was found. Chronic social stress
increased amphetamine-induced locomotion (Mathews et al.
2008) and vice versa (Antelman et al. 1980;M y i n - G e r m e y s
and van Os 2007; Vanderschuren et al. 1999). Withdrawal
Transcription factor analysis
Gene set
CA1 qPCR R2K
P
e
r
c
e
n
t
 
o
f
 
g
e
n
e
s
 
i
n
 
s
e
t
 
m
a
t
c
h
i
n
g
0
5
10
15
20
25
30
35
CREB
GR 
Mef2 
Fig. 6 Comparison of genes regulated in CA1, NAc, and PFC to
genes involved in specific transcriptional regulation as identified by
ChIP/ChIP experiments. For each of the brain areas, the comparison
was made for the genes identified in expression array and for those
confirmed by qPCR. The R2K dataset represents 10×2,000 random
probe sets, indicating background signal and size difference of ChIP/
ChIP datasets used. Genes compared are those listed in Supplementary
Table SI and shown in Fig. 4. (Supplementary Table SIII)
Psychopharmacology (2011) 217:525–538 533from amphetamine leads to increased corticosterone levels in
rats that show sensitization but not in nonsensitized animals
(Scholl et al. 2009). DBA/2 mice are known for their
vulnerability to stressful events (Weaver et al. 2004). Our
findings indicate that several of the genes that are differen-
tially expressed between LR and HR are involved in
glucocorticoid signaling. For example, Nr4a1 was one of
the IEGs we identified to have a higher expression in the
CA1 of HR. Nr4al belongs to the family of orphan nuclear
receptors and is also increased by amphetamine in the
striatum (Levesque and Rouillard 2007). Nr4a1 is known to
bind to NGFI-B sites in addition to glucocorticoid response
elements (GREs). It has been shown that Nr4a1 can compete
with the GR for binding to a negative GRE sequence on the
Pro-opiomelanocortin (POMC) promoter in the hypothala-
mus, preventing the GR-induced inhibition of Adrenocorti-
cotropic hormone (ACTH) (Okabe et al. 1998; Philips et al.
1997), which is part of the negative feedback of the
hypothalamic–pituitary–adrenal (HPA) axis and vital for
proper functioning of the stress system. Several others of
the differentially expressed genes we identified are gluco-
corticoid responsive, such as Dusp1 (King et al. 2009).
Hippocampal Dusp1 expression is known to be induced by
glucocorticoids (Morsink et al. 2006), suggesting that HR
have an increased corticosterone response to the amphet-
amine challenge, corresponding to a sensitized HPA axis.
Mef2 The transcription factor Mef2 plays a role in regulation
of IEGs and behavioral sensitization. Mef2 is a key regulator
of structural synapse plasticity and has recently been impli-
catedinbehavioralsensitizationtococaine(Flavelletal.2008;
Livak and Schmittgen 2001). Chronic cocaine treatment was
shown to affect Mef2 phosphorylation in the NAc, thus
altering its activity (Pulipparacharuvil et al. 2008). Mef2 is
phosphorylated and consequently inhibited by Cdk5 in
combination with its activators p35 and p25 (Gong et al.
2003). p25 protein level, responsible for a prolonged
activation of Cdk5, was shown to be increased 4 h after
acute or chronic amphetamine treatment (Mlewski et al.
2008) and might explain the altered activity of Mef2 during
psychostimulant sensitization. Expression of Cdk5 itself can
be directly regulated by ΔFosB (Kumar et al. 2005) that in
turn is increased after psychostimulant treatment and can
remain elevated for weeks (Nestler 2005b). Cdk5 not only
phosphorylates Mef2 but was also found to phosphorylate
GR in a dexamethasone-dependent manner (Kino et al.
2007). Consequently, amphetamine-induced changes in Cdk5
may affect both GR and Mef2 transcriptional activity. This
suggests that the glucocorticoid stress system and Mef2-
driven pathways converge and would provide an explanation
for how individual differences in stress can affect the
sensitization process. Interestingly, Mef2 expression itself
was not found to be different between LR and HR.
cAMP response element binding We found that CRE family
transcription factors overall can affect at least 15% of qPCR
confirmed AMPH-regulated genes in CA1 (Fig. 6). In a
random set of genes picked from the gene expression chip,
this number is low (3.4%, see Fig. 6). This CRE family
transcription factor overrepresentation is in line with the
literature. The CREB protein is a transcription factor that
binds to CRE DNA signature sequences and, thereby,
increases or decreases the transcription of downstream
genes (Purves et al. 2008). Genes relevant for amphetamine
sensitization and DA function whose transcription is
regulated by CREB include c-fos, brain-derived neuro-
trophic factor (BDNF), tyrosine hydroxylase, and many
neuropeptides (such as somatostatin, enkephalin, VGF, and
corticotropin-releasing hormone) (Purves et al. 2008).
CREB has a well-documented role in neuronal plasticity
and long-term memory formation in the brain (Silva et al.
1998). Altered cAMP signaling was previously identified to
be one of the most consistent changes in the striatum in an
extensive study using three genetic and one pharmacological
mouse models of psychostimulant or DA supersensitivity
(Yao et al. 2004). The molecular and cellular mechanisms
underlying plasticity related to behavioral sensitization to
psychostimulants and learning and memory may be similar
(Yao et al. 2004). This fits well with our observations that
CREB and GR, both known to be important for learning and
memory, may be key transcription factors regulating behav-
ioral sensitization to amphetamine.
Environmental factors Since all mice from this inbred
strain received an identical treatment, a plausible underly-
ing cause for difference in sensitization may be that
differences in handling, social hierarchy, or maternal care
underlie the differential expression of amphetamine sensi-
tivity via effects on the glucocorticoid stress system
(Badiani et al. 1992; Holmes et al. 2005; Lockwood and
Turney 1981). This fits well with the numerous studies
pointing to an association between early childhood trauma,
parental care, and social adversity and the later development
of psychotic illness (Janssen et al. 2004; Morgan and Fisher
2007;M o r r i se ta l .2006; Wicks et al. 2005). The stress
system may be an important biological mechanism linking
sensitization processes initiated by developmental stress
exposures to an increased risk for psychosis. Recent studies
have shown changes in cortisol secretion associated with
smaller left hippocampal volume in first-episode psychosis
patients (Mondelli et al. 2010b) and a blunted cortisol
awakening response compared with controls (Mondelli et al.
2010a) and increased emotional reactivity to stress in daily
life (Lataster et al. 2009).
Technical considerations In the current study, we demon-
strated that there are individual differences in gene
534 Psychopharmacology (2011) 217:525–538expression in key dopaminergic output areas in the brain
that reflect a differential sensitivity to amphetamine. Differ-
ences in gene expression in all three brain regions were
subtle, with the majority of gene expression changes being
below 1.5-fold. These modest changes in gene expression
are not surprising, given that LR and HR have the same
genetic background and received an identical sensitization
protocol using exactly the same amphetamine dosing
regimen. Nonetheless, our setup using LMD in combination
with DNA microarrays is evidently sensitive enough to
detect these changes. Validation of the identified gene
expression changes proved to be difficult, in particular in
the NAc and PFC. Validation of subtle differences in gene
expression by other methods such as RT-qPCR is notori-
ously difficult due to limitations in sensitivity. Most
commonly, a twofold change is reported as the cutoff
below which microarray and qPCR data begin to lose
correlation. Dallas et al. (2005) reported decreased correla-
tions for genes expressing <1.5-fold change using qPCR
and oligonucleotide microarrays. Nonetheless, we were
able to validate 22 out of 87 genes with RT-qPCR, with the
highest success rate (50%) in the CA1 region of the
hippocampus. Detection of false positives may also have
contributed to the relatively low success rate of validation.
Using a microarray with 45,000 probe sets, a p value of
0.01 is likely to yield 450 false positives.
While comparing gene expression differences between
LR and HR with the same genetic background and an
identical sensitization protocol is the strength of the current
study, a limitation is that we did not perform gene
expression measurements in response to amphetamine
challenge in the nonsensitized saline group as a reference.
Sources of experimental uncertainty We have a high level of
confidence in our CA1 array data for the following reasons.
First, the genes identified here are based on strong statistical
comparisons with ten biological replicates in each group,
decreasing the probability of false negatives. This is in
contrast to a majority of published reports where either small
numbers of animals are used in each comparison group or
technical replicates of pooled animals are applied to identify
targetgenes (Pawitanetal.2005). Second, rather than using a
whole hippocampus homogenate, we specifically isolated the
CA1 pyramidal cell layer, resulting in a more homogeneous
population of neurons highly enriched for CA1 pyramidal
neurons and, therefore, more likely to yield a transcriptional
response that is undiluted by effects in other parts of the
hippocampus, non-neuronal cells such as glia and isolation
artefacts. We have previously demonstrated that the different
subregions of the hippocampus differ profoundly in basal
transcriptome, demonstrating that the brain-specific isolation
and analysis of homogeneous neuronal subpopulations is of
utmost importance (Datson et al. 2004;D a t s o ne ta l .2009).
Third, the validation rate was high considering the small
differences in expression. Finally, RT-qPCR remeasurement
of representative genes in an independently performed
follow-up experiment demonstrated that the changes in gene
expression in CA1 were reliably reproduced and correlated
with the HR or LR phenotype.
Timing The time at which the gene expression changes
were measured in the current study, i.e. 1 h after an
amphetamine challenge, is a point of consideration. Our
rationale for choosing this time point was that we wanted to
investigate gene expression between LR and HR under
challenged rather than baseline conditions, which we hypoth-
esize is a prerequisite to identify pathways relevant for
behavioral sensitization and thus susceptibility for psychosis.
Under challenged conditions, the phenotypic extremes between
LR and HR become evident, while under basal conditions there
are no apparent differences. Furthermore, the current design is
appropriate for detecting primary gene responses rather than
secondary or even more downstream waves of gene expression.
It could be argued that looking at a later time point would give
more insight in the long-lasting changes in gene expression
rather than in acute changes associated with the amphetamine
challenge. Indeed, Cadet et al. (2001) found differential gene
expression in the frontal cortex up to 16 h after a 40 mg/kg
dose of methamphetamine, although this dose is much higher
(32-fold higher) compared to the rather low doses given in our
study. Nonetheless, the success of our approach is evident
since the changes in gene expression we identified in CA1
reproducibly discriminate HR from LR, as demonstrated in the
independent follow-up experiment we performed.
In conclusion, we show that inbred DBA/2 mice exhibit
large differences in sensitization to amphetamine that is
reflected at the transcriptional level in several dopaminergic
output brain areas, but in particular in the CA1 area of the
hippocampus. We have identified CRE, Mef2, and GR
transcription factors as possible mediators of these differ-
ences. CRE, Mef2, and GR signaling appears to form a
transcription regulation network involved in the amphet-
amine susceptibility response and thus may play an
important role in psychosis susceptibility. To which extent
these systems act as independent, linked, or sequential
programs is the target of future studies.
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